Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) released its earnings results on Wednesday. The company reported ($0.53) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.59) by $0.06, Briefing.com reports. The company had revenue of $0.04 million during the quarter, compared to analyst estimates of $0.01 million. Allogene Therapeutics had a […] The post Allogene Therapeutics (NASDAQ:ALLO) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS first appeared on Daily Political .

https://www.dailypolitical.com/2023/08/04/allogene-therapeutics-nasdaqallo-releases-quarterly-earnings-results-beats-estimates-by-0-06-eps.html

#dailypolitical